Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
10.16
+0.22 (2.21%)
At close: Oct 19, 2026, 4:00 PM EDT
10.25
+0.09 (0.88%)
After-hours: Oct 19, 2026, 7:59 PM EDT
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $603.34 million as of October 19, 2026. It is the 13,305th most valuable company in the world and the 2,601st biggest in the United States. Its market cap has decreased by 0.52% in one year.
Market Cap
603.34M
Enterprise Value
383.27M
1-Year Change
-0.52%
Global Rank
Country Rank
#2,601 United States
Category
ChartMarket Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $603.34M, an increase of 337.84%. That is a compound annual growth rate of 13.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 603.34M | 19.62% |
| Dec 31, 2025 | 504.40M | 13.30% |
| Dec 31, 2024 | 445.20M | 87.69% |
| Dec 29, 2023 | 237.20M | 49.75% |
| Dec 30, 2022 | 158.40M | -48.50% |
| Dec 31, 2021 | 307.60M | 505.51% |
| Dec 31, 2020 | 50.80M | 303.17% |
| Dec 31, 2019 | 12.60M | -73.25% |
| Dec 31, 2018 | 47.10M | -20.71% |
| Dec 29, 2017 | 59.40M | 37.50% |
| Dec 30, 2016 | 43.20M | -84.95% |
| Dec 31, 2015 | 287.00M | 108.27% |
| Apr 16, 2015 | 137.80M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Attovia Therapeutics | 626.79M |
| Candel Therapeutics | 626.69M |
| Prime Medicine | 617.33M |
| Wave Life Sciences | 616.76M |
| Nuvectis Pharma | 607.65M |
| Avalo Therapeutics | 604.41M |
| Solid Biosciences | 592.96M |
| Olema Pharmaceuticals | 575.73M |